Early Day Motion 208
Enhertu for metastatic breast cancer patients
Tabled 1 June 2026 by Clive Jones
That this House recognises the recent changes to NICE’s cost effectiveness threshold, which could facilitate better access to new medicines; expresses concern that Enhertu, a treatment for people with incurable HER2-low metastatic breast cancer, remains unavailable to patients on the NHS in England; welcomes Breast Cancer Now's Enhertu Now campaign, supported by METUPUK and Make 2nds Count; and urges pharmaceutical companies Daiichi Sankyo and AstraZeneca, NHS England and NICE to reach a deal to make Enhertu available to those who urgently need it to give them more time to live.
Signatories (51)
- Clive Jones Sponsor
- Vikki Slade
- Mr Will Forster
- Jess Brown-Fuller
- Jim Shannon
- Wera Hobhouse
- Andrew George
- Gideon Amos
- Mr Lee Dillon
- Dr Roz Savage
- Sorcha Eastwood
- Cameron Thomas
- Sarah Dyke
- Pippa Heylings
- Mr Paul Kohler
- Mary Kelly Foy
- James MacCleary
- Rachel Gilmour
- Jim Allister
- Wendy Chamberlain
- Emma Lewell
- Mr Joshua Reynolds
- Manuela Perteghella
- Jon Trickett
- Tom Gordon
- Helen Maguire
- Steve Witherden
- Patricia Ferguson
- Freddie van Mierlo
- Dr Scott Arthur
- Neil Duncan-Jordan
- Alex Easton
- Tessa Munt
- Zöe Franklin
- Caroline Voaden
- Chris Hinchliff
- Martin Wrigley
- Kim Johnson
- Ian Sollom
- Luke Taylor
- Layla Moran
- Tom Morrison
- Tim Farron
- Dr Ellie Chowns
- Luke Akehurst
- Hannah Spencer
- Dr Al Pinkerton
- Cat Smith
- Daisy Cooper
- Bell Ribeiro-Addy
- Olivia Blake
Source
UK Parliament EDM data